InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.1%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Moreadith Randall, Chief Scientific Officer. Officer active across 1 company, notably Serina Therapeutics, Inc.. Aggregated, 26 reports have been published. History available since 25 August 2025. The latest transaction was disclosed on 2 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations26 total
6,500 shares@ US$0.065.1% of flowCommon StockSEC:0001301120-26-000012
6,500 shares@ US$0.060.0013% mcap5.1% of flowCommon StockSEC:0001301120-26-000012:0
6,500 shares@ US$0.065.0% of flowCommon StockSEC:0001301120-26-000010
6,500 shares@ US$0.060.0013% mcap5.0% of flowCommon StockSEC:0001301120-26-000010:0
5,416 shares@ US$0.064.3% of flowCommon StockSEC:0001301120-26-000004
5,416 shares@ US$0.060.0011% mcap4.3% of flowCommon StockSEC:0001301120-26-000004:0
13,000 shares@ US$0.0610.4% of flowCommon StockSEC:0001301120-26-000002
13,000 shares@ US$0.060.0027% mcap10.4% of flowCommon StockSEC:0001301120-26-000002:0
5,673 shares@ US$0.064.5% of flowCommon StockSEC:0001301120-25-000037
5,673 shares@ US$0.060.0012% mcap4.5% of flowCommon StockSEC:0001301120-25-000037:0
1,700 shares@ US$0.060.0004% mcap1.3% of flowCommon StockSEC:0001301120-25-000033:0
1,700 shares@ US$0.061.3% of flowCommon StockSEC:0001301120-25-000033
3,555 shares@ US$0.062.8% of flowCommon StockSEC:0001301120-25-000030
3,555 shares@ US$0.060.0007% mcap2.8% of flowCommon StockSEC:0001301120-25-000030:0
600 shares@ US$0.060.5% of flowCommon StockSEC:0001301120-25-000027
600 shares@ US$0.060.0001% mcap0.5% of flowCommon StockSEC:0001301120-25-000027:0
1,500 shares@ US$0.061.2% of flowCommon StockSEC:0001301120-25-000025
1,500 shares@ US$0.060.0003% mcap1.2% of flowCommon StockSEC:0001301120-25-000025:0
5,551 shares@ US$0.060.0012% mcap4.4% of flowCommon StockSEC:0001301120-25-000013:0
5,551 shares@ US$0.064.4% of flowCommon StockSEC:0001301120-25-000013
6,500 shares@ US$0.065.2% of flowCommon StockSEC:0001301120-25-000009
6,500 shares@ US$0.060.0014% mcap5.2% of flowCommon StockSEC:0001301120-25-000009:0
4,326 shares@ US$0.063.5% of flowCommon StockSEC:0001301120-25-000007
4,326 shares@ US$0.060.0009% mcap3.5% of flowCommon StockSEC:0001301120-25-000007:0
2,042 shares@ US$0.061.6% of flowCommon StockSEC:0001301120-25-000005
25 of 26 declarations
About Moreadith Randall
Moreadith Randall is the Chief Scientific Officer of Serina Therapeutics, Inc. She oversees the company's research and development initiatives.
